Business formation first jumped in 2020 as the pandemic reorganized work, shopping and logistics. After the pandemic ended, business formation leveled off, but it did not return to its old path. It remained historically high. Moreover, in the past 18 months or so business formation has surged again. Registered Agents Inc tracks new Articles of Organization or Incorporation filed in the 50 states and they report:

Every month in 2026 has set a new formation record, including March, which stands as the highest single-month total in the history of the Business Formation Report. Through May, 2.9 million new businesses have been formed nationwide, the strongest five-month start on record.

Stripe Economics agrees and calls this the age of the solopreneur.  Among businesses using Stripe, recent cohorts are reaching serious transaction volumes faster than earlier cohorts.

The share of businesses (not just solopreneurs) reaching $1 million in cumulative revenue within a year after going live on Stripe was roughly 30% higher for the 2025 cohort as it was for the 2023 cohort, and it was roughly 3x higher for the 2025 cohort than the 2019 cohort.

Furthermore, the trend is not just in the United States. France, where, as the story goes, they have no word for entrepreneur, has also seen business creation reach record levels, driven heavily by micro-entrepreneurs.

The most likely explanation is the devolution of power. A single person armed with Stripe, Shopify, cloud software, automated bookkeeping, and now AI can do what once required a small staff. Dynamism had been on a long secular decline, but we may now be seeing the early stages of an experimental economy—one in which far more people can test ideas, reach customers, and launch firms, some of which will grow very large, very fast.

The post New Business Formation is Surging–Again. appeared first on Marginal REVOLUTION.

       

Comments

• Isn't “entrepreneur” a French word? And in Paris there is ... by Bernhard Scholz

Related Stories

• Elderly Health and Longevity in the US
• I am told James Mill is buried there also
• Translated from the Chinese

 

St. Mary’s Abbot’s Church in Kensington.

The post I am told James Mill is buried there also appeared first on Marginal REVOLUTION.

       

Comments

• AI: “A master in chancery is a court-appointed officer who ... by rayward
• Why does the link go to “chatgpt.com”? From now on ... by Patrick

Related Stories

• Alan Greenspan, RIP
• New Business Formation is Surging–Again.
• Translated from the Chinese

 

I think this is the Cursor moment for academia.

The Stanford REAP team has made their move, http://CoPaper.AI is mass-terminating the manual labor of traditional empirical papers. Link: https://copaper.ai/landing

If using large models to write papers before was just about polishing and compiling references for you, then this Project from Professor Ross Griebenow’s team at Stanford is like dropping a nuclear bomb in the empirical circles of social sciences and economics.

The greatest truth is the simplest; the heaviest sword has no edge. Its functions are straightforward. Feed in the raw dataset, and within 30 minutes, it can generate a complete DOCX paper complete with full Stata/R code and publication-quality charts.

It chains together EDA, variable definition, econometric model building (from OLS to advanced DID, regression discontinuity, causal forests) all using an Agent workflow.

Every chart it produces comes with 100% reproducible Stata, R, EViews source code underneath. How many low-quality paper mills and data drones’ jobs will this smash?

Data drones and paper ghostwriters are collectively facing unemployment countdown. Because from now on, for social science papers, AI handles all the entropy-increasing drudgery—humans only need to define the problem.

Here is the link.  Mostly that is not true, so perhaps the Chinese are trying to demoralize us.  But will it never ever be true?  In two years be true?  Less?

The post Translated from the Chinese appeared first on Marginal REVOLUTION.

       

Comments

• In reply to Quantitative Sneezing. “They still seem to be ... by Kaz Stanczak
• In reply to Kaz Stanczak. They still seem to be researching ... by Quantitative Sneezing
• In reply to Rahul. Writing papers is more than just the final ... by Eze Tua
• In reply to rayward. >Way down here while there are some ... by Mitchell
• In reply to bazza. 'True mastery relies on formlessness.' ... by b
• Plus 10 more...

Related Stories

• Alan Greenspan, RIP
• How research in math will change (from my email)
• AI-Native Firms

 

Do not focus the discourse on aliens, rather focus on whether the phenomena are real.  If they are confirmed as real, as many insiders insist, they we can return to debating what they might be.  And focusing on concrete evidence is something a committee can be relatively good at.  Trying to find agreement on “aliens” does not fall into that same category.

The post What should the UAP Scientific Advisory Board do? appeared first on Marginal REVOLUTION.

       

Comments

• What should the UAP Scientific Advisory Board do? => resign ... by Fernando
• I quickly read the first sentence as “There are more and more ... by Diogo
• In reply to Dismalist. Try as one might to weasel out of the ... by Grognard de Betelgeuse
• “There are more and more frauds, charlatans, and lunatics ... by KenF
• In reply to Gardel. I wish I could upvote you 100 times. All ... by Someone
• Plus 10 more...

Related Stories

• Is the UK improving?
• Alan Greenspan, RIP
• California’s Gay Certification Program

 

2. Why is China still exporting T-shirts?

3. Greenspan and Keynes crossed paths in 1944.  Clarinet!

4. Robert Shiller opposes AI negativity (NYT).

5. The opportunity cost of Trae is really not that large.  Think in terms of opportunity cost here, not “cost.”  By the time the Wizards need to up the pay of their younger players, Trae’s contract will be expiring.

6. “A new bill seeks to restrict who can and cannot teach a course at the California State University’s 22 campuses. The criterion, though, is pretty simple: to be a professor, you must be human.“

The post Wednesday assorted links appeared first on Marginal REVOLUTION.

       

Comments

• 6. You mean we don't have to be gay to teach in CA?! by Franzish
• In reply to Tom T.. > hold down wages by restricting worker ... by European Troll
• In reply to rsm. ChatGPT: Foreigners probably own about ... by Kaz Stanczak
• Important addendum that makes my point very clear: Foreigners ... by Kaz Stanczak
• In reply to rsm. ChatGPT (paid ver) disagrees: ... by Kaz Stanczak
• Plus 10 more...

 

GLP-1 medications generate large weight loss and may also alter social and economic outcomes. Using the Understanding America Study, I compare women starting GLP-1s for weight loss with matched women who would like to start a GLP-1 but have not. Single women’s marriage/cohabitation rates rise by 29 percentage points and employment among baseline non-employed women rises 27 percentage points after six or more quarters. Existing partnerships do not dissolve, and already-employed women show no upward job mobility. The pattern suggests that part of the female obesity penalty operates at new-match formation rather than only through health or incumbent productivity.

Here is the paper by Rebecca Diamond.  And here is a thread on the paper.  And not everyone believes the size of these estimates.  I do not find them so crazy?  Here is Steven’s dialogue with GPT.

The post GLP-1 drugs and marriage appeared first on Marginal REVOLUTION.

       

Comments

• In reply to Phil S.. Yes. Anything that helps with any ... by Pipsterate
• In reply to Gilligan. This used to be the norm for much of ... by Aretino
• In reply to Patrick. You mean, perhaps we should be more like ... by anonprof
• In reply to anonprof. Yes, I think this exactly quantifies ... by Marie
• In reply to Patrick. Walk a half mile through Newark every ... by Ira Gilligan
• Plus 10 more...

Related Stories

• Elderly Health and Longevity in the US
• Two Roads to Fast Clinical Trials, and the US Takes Neither
• Music markets remain deglobalized

 

Guilherme Pinho, Sao Paulo, real estate titling and transactions in Brazil.

Diyar Zhakpelov, Astana, Kazakhstan, 17, exam prep app for Kazakhs, general career support.

Randy Chang, AI policy writings, Ontario/Chapel Hill.

Jesse Casana, Dartmouth, archaeology tranche, “Drone-acquired synthetic aperture radar (SAR), a novel and experimental technology, reveals remarkable perspectives on buried archaeological landscapes in the desert southwest.”

Gia-Bao Dam, New Haven/Yale, longevity research.

Sasha Lempers, Annecy, France, 15, math and AI.

Ali-Mansur Valiyev, Harihar Rengan, Dubai, high school, general career support, educational testing.

Raiani Romanni-Klein, Boston/Cambridge, a non-profit on the implications of biological innovation.

Clara Collier, Oakland, Asterisk magazine.

Scott Ellis, Mississauga, science education tranche, biographies of scientists on YouTube.

Jim Olds, northern Virginia, writings on science policy, science education tranche.

The post Emergent Ventures winners, 55th cohort appeared first on Marginal REVOLUTION.

       

Comments

• Is it okay that when I saw ‘Asterix’ I was secretly hoping ... by dmcharette
• Asterisk. Remarkable how similar it seems in tone to the old ... by Public Choice
• > Asterisk Magazine If they are trying to write about policy ... by Stendell
• Yay Clara Collier! by Andy

Related Stories

• Translated from the Chinese
• My Conversation with Dave Baszucki
• A Cohort Perspective on Latin America’s Fertility Transition

 

2. Benny Goodman and Lionel Hampton doing “I Got Rhythm.”

3. Claims about advancements in cancer testing.

4. Reconstructing Welles’s Don Quixote?

5. The obesity penalty in political elections.

6. Zvi on GLM-5.2.

7. New work by Mozart.  And more information here.

8. Chad Jones going on leave to Anthropic.

The post Tuesday assorted links appeared first on Marginal REVOLUTION.

       

Comments

• In reply to Ai. This is a simple and gross generalization ... by What's the frequency Kenneth?
• In reply to Rebes. Very under underrepresented in society. Is ... by Paulo
• In reply to Nick A. They seriously could! And the awesome ... by Dzhaughn
• #7. The second link is to news from 2024… by Nick
• 5. Candidate formation now includes 6 months of GLP-1s. by Hudson Valley
• Plus 10 more...

 

China has made biotechnology a strategic national priority, systematically expanding its clinical research infrastructure with government backing, streamlined regulatory pathways, and sustained investment. In 2021, China’s global share of Phase 1 trials surpassed the United States’ share for the first time, a milestone that would have seemed unlikely just a decade earlier. And in 2024, China surpassed the United States in the total number of clinical trials registered, with over 7,100 registered, representing 39% of global trials…. For certain cutting edge modalities, including cell and gene therapy, radioligand therapy, and stem cell therapy, China uses investigator-initiated trials to provide additional flexibility, though with some tradeoffs around oversight and quality control. This means that drugs can move into human testing if a researcher has an interest and funding. In the U.S., comparable trials might wait years to start.

I am also pleased to see that they mention Australia, another advanced democracy, as a leader in clinical trial regulation:

Australia’s Clinical Trial Notification System allows trials to begin in fewer than 70 days after a final protocol is submitted, with regulatory approval granted in as little as 21 to 28 days and sites activated within 6 to 12 weeks.

Keep those comparisons in mind. Operation TrialBlazer proposes some good reforms such as CMC clarification. CMC is Chemistry, Manufacturing, and Controls–and it deals with the basics of manufacturing a drug. The FDA, however, is very risk averse and companies know that so they have often gone overboard in CMC: for example, proving stability of a formula at 6+ months when the trial is to last only a few weeks or documenting their full commercial manufacturing process before they even know if the drug works and knowing full-well that the process will be changed many times before a drug actually gets to market. In short, a lot of cost for very little benefit. The FDA is now clarifying that this kind of thing is not necessary. Good, that is low-hanging fruit. There are other good ideas as well.

But note what they are not proposing. Despite using China and Australia as exemplars they are not going down either path. Where China is fastest is in cell therapy, gene therapy, radioligand, and stem cell work and in these areas, China lets trials proceed on an investigator-initiated basis: as the TrialBlazer document puts it, a drug can move into humans “if a researcher has an interest and funding.” China then combines this open (or lax) front end (for these products) with an all-of-government industrial policy to accelerate winners.

The US is declining to go down that path. Ok, not my call, but I get it. But they are also declining to follow Australia. In Australia there is also no government prospective regulatory evaluation of most early-phase clinical trials. Under the Clinical Trial Notification (CTN) scheme, the sponsor submits their protocol package to a Human Research Ethics Committee (HRECs)–Australia’s IRBs–and once the ethics committee approves, the sponsor notifies the regulator, the Therapeutic Goods Administration (TGA), and pays a fee. The TGA does not read and clear the package before the trial starts. The roughly 21-to-28-day “approval” and sub-70-day start figures in the document are fast precisely because the regulatory step is not an evaluation. The government regulator stays out of the front end for most clinical trials, although in direct contrast with China it does step in for the highest risk biologicals. China has decided, high-risk, high-reward.

Australia does certify the certifiers, the HRECs. Europe uses a similar system for medical device approval. It’s a system proposed by former medical officer at the FDA Henry Miller and one I have long supported for the US. China is more laissez-faire.

The US architecture in contrast rests on the “gold standard” FDA reviews and the “FDA will retain full regulatory authority and decision-making.” In short, all of the TrialBlazer reforms are about making the gatekeeper faster, cheaper to prepare for, and less uncertain. None of it is about getting rid of the gatekeeper.

Addendum: Full disclosure, I did some consulting with ARPA-H on related work. See also my previous post on the a radical deregulatory approach, Montana’s SB535 and a Potential Biotech Renaissance in America

The post Two Roads to Fast Clinical Trials, and the US Takes Neither appeared first on Marginal REVOLUTION.

       

Comments

• In reply to rayward. Great points, however a few ... by Ari T
• “Australia does certify the certifiers, the HRECs. Europe ... by skyzyks
• In reply to Wayfaring Stranger. I know, right? Also rather ... by zardoz
• In reply to Public Choice. So… because the restrictive ... by zardoz
• In reply to rayward. Yep that’ll help get us more miracle ... by Kyle
• Plus 10 more...

Related Stories

• Elderly Health and Longevity in the US
• California’s Gay Certification Program
• Montana’s SB535 and a Potential Biotech Renaissance in America

 

From a very credible Labour source:

– Wes Streeting promised the Chancellorship for not running.

– Capital gains raised to match income tax. Possible exit tax.

– Economic focus: devolution, plus state ownership of cost-of-living essentials (energy, water, transport).

– Nothing on AI or tech, bar higher capital gains and an EIS/SEIS-style relief for backing British businesses. (Spoiler: startups now incorporate in Delaware and raise on SAFEs. I’ve done 60+ angel investments; only two were eligible.)

Andy and Wes don’t seem to grasp that tech has been the core engine of growth for 20 years, and AI will only accelerate that.

So why would any founder build here? How does the UK compete with the US and China on AI? Where does growth actually come from?

The world economy is changing fast, and we need to be ready to thrive in it, not just survive.

I really hope this admin appoints some figures who actually get what’s happening. Losing business support early, from a disastrous first budget, was the beginning of the end for Starmer.

So, in a nutshell, no, the UK is not improving.

The post Is the UK improving? appeared first on Marginal REVOLUTION.

       

Comments

• In reply to derek. Sounds like a fine idea as well, but ... by CB
• In reply to M. For the seats that Labour needs to hold, it is ... by SJ
• In reply to Tom T.. To which we can add a worrying ... by Thor
• In reply to SJ. The pattern of switching is discussed, what ... by M
• In reply to M. M, the UK prime minister has just been forced ... by SJ
• Plus 10 more...

Related Stories

• What should the UAP Scientific Advisory Board do?
• Alan Greenspan, RIP
• California’s Gay Certification Program

 

In 2014 I wrote in The New York Times that if your own team is not in the World Cup, you should root for the one whose victory would do the most good. Add up the happiness a title would create, more where more people care, more where incomes are lower, and more where a win would be a first rather than a habit, and root for the country on top. That year it was Nigeria. With 48 teams in 2026, and more of the world’s poorer and first-time sides in the field, I rebuilt the guide, with more nuance and, thanks to AI, at a fraction of the old cost. It updates itself as the games are played.

At least for now, you should root for the DRC he argues.

The post Dean Karlan has a Substack appeared first on Marginal REVOLUTION.

       

Comments

• Interesting to read different perspectives on what it means to ... by BC
• In 2014 I wrote in The New York Times that if your own team is ... by Zach
• In reply to Steve Sailer. Consequentialist type arguments of ... by Eric Mack
• In reply to Steve Sailer. Or you could just ignore the ... by Wayfaring Stranger
• I'm sorry, but this is truly the core issue with left-wing ... by tds
• Plus 10 more...

Related Stories

• Safety and nation-building in Mexico

 

Rising elderly life expectancy is a well-known source of fiscal pressure on Social Security and Medicare – but how have declining mortality and morbidity affected the two programs’ relative finances? Using nearly three decades of Medicare Current Beneficiary Survey data (1992-2019), we estimate that these demographic changes raised expected lifetime Social Security spending by over twice as much as expected lifetime Medicare spending: 14% compared to 6%. The slower growth of elderly lifetime health care spending than annuity spending reflects two features of how longevity has increased: the additional 2.4 years of remaining life expectancy were entirely healthy – free of physical or cognitive limitations – while the expected amount of time spent with severe health limitations fell by about 30%, reducing expected lifetime nursing-home and home-health use. We then write down a stylized life-cycle model of a risk-averse retiree facing stochastic mortality and health to illuminate the key forces that affect the optimal allocation of a fixed amount of public funds across Medicare and Social Security.

That is from a new NBER working paper by Liran Einav and Amy Finkelstein.  In general I wish to switch resources from Medicare to Social Security, or at least give individuals the option to do so.  You can use dollars to buy health care, but it is not always so easy to make the transformation in the opposite direction.

The post Elderly Health and Longevity in the US appeared first on Marginal REVOLUTION.

       

Comments

• In reply to rayward. I have a cousin turning 90 next month. ... by JonFraz
• In reply to mkt42. Damn straight. No mystery ingredients in ... by Excursive
• In reply to Excursive. China prohibits all driving after 80. ... by David Blair
• In reply to Excursive. So annual baking tests as well as ... by mkt42
• I know medically fragile multi-millionaires on Medicare. Also, ... by Anti-Gnostic
• Plus 10 more...

Related Stories

• GLP-1 drugs and marriage
• Two Roads to Fast Clinical Trials, and the US Takes Neither
• I am told James Mill is buried there also

 

The new book you can order here.

The post *The Migrants: A Memoir with Manuscripts* appeared first on Marginal REVOLUTION.

       

Comments

• In reply to Seong of Baekje. Which leads to the question: ... by mkt42
• That is a great book. I regret that I don't have time before ... by Michael Tinkler
• Ordered. Sounds great. by Smug Belgian
• Dunedin Celtic “dun” (hill, fort) also being the origin ... by Seong of Baekje

Related Stories

• The Free Press summer reading list
• My aesthetics podcast with Benjamin Lima
• Orwell on Dickens and progress

 

2. “The Royal Society for Blind Children and the National Deaf Children’s Society have both come out against the Starmer social media ban.”

3. Persistently beneficial AI models.  Through general benevolence.

4. “Concerns over therapy ferrets used to kill rats at UK’s largest children’s prison.”

5. So you fly from Australia to London over the North Pole?

6. Will Burnham reverse “privatisation”?

The post Monday assorted links appeared first on Marginal REVOLUTION.

       

Comments

• In reply to M. My kids couldn't do without their [invitation ... by bazza
• In reply to M. They were called borstals [in NZ and probably ... by bazza
• In reply to bazza. At the time we had a young cat that was ... by bazza
• In reply to RAD. what would actually look different in a ... by r_r
• In reply to rsm. it helps that a lot of predators are ... by r_r
• Plus 10 more...

 

The post Alan Greenspan, RIP at 100 appeared first on Marginal REVOLUTION.

       

Comments

• In reply to boomersooner. Yes, I did a double-take when I saw ... by mkt42
• In reply to Heedless. I looked at that too. I look forward to ... by anonprof
• Interesting, if this still holds true ... by reader
• In reply to mkt42. When I glanced at that photo for a sec I ... by boomersooner
• In reply to Steven. That's not the lesson of the pandemic. by Covid Toes
• Plus 10 more...

Related Stories

• California’s Gay Certification Program
• Bastiat’s telephone?
• Adrian Wooldridge on Sweden and liberalism